This is James DuCanto‘s talk at the airway session at The Bick Sick in Zermatt, 2018.

Jim is well known in the FOAM sphere and beyond for his passion on airway management and is a very dedicated and ingenious inventor of equipment for airway simulation and airway management.

In recent years, Jim has focused a lot of energy on the SALAD concept (suction assisted laryngoscopy airway decontamination) which essentially is continuous suctioning of the airway through the whole intubation process. He has demonstrated it at numerous conferences throughout the world including, now, in Zermatt for TBS. The amount of flights cases he drags around the world for the setup is quite insane and a testiment to Jim’s no holds barred approach to life. If you get a chance to try it out do take it, as it’ll probably be your one shot at intubating a regurgitating wookie with a laryngoscope fitted to an axe.

For more information on DuCanto’s work visit his website.

Follow Jim down the rabbit hole of contaminated airways in this talk.

Geir Strandenes' talk at The Bick Sick in Zermatt, 2018.

Geir does a tour de force on blood transfusion, its history, physiology, the evidence base and ongoing developments in prehospital transfusion practice in both civilian and military settings. He specifically adresses how to apply principles of damage control resuscitation to remote locations and the introduction of fresh whole blood prehospitally from the point of injury onward.

Geir represents the THOR network (Trauma Hemostasis and Oxygenation Research network) where you can find more information

https://rdcr.org/

Find the rest of the talks from The Big Sick on scanfoam:

https://scanfoam.org/category/conference-talks/the-big-sick-2018/

Samuel Tisherman at The Big Sick 2018 in Zermatt.

This is the story of deep hypothermia as a means of buying time to surgically save the lives of otherwise unsalveagable trauma patients.

This is essentially suspended animation.

Hear how this technique has evolved from one of the pioneers and learn about the ongoing efforts to establish its potential benefits in humans through the EPR-CAT study.